Follow
Nanoform Finland Oyj
Nasdaq First North GM (Finland)
Nasdaq First North GM (Sweden)
Nanoform Finland PLC is an nanoparticle medicine enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nanoforming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nanoformed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by incre Nanoform Finland PLC is an nanoparticle medicine enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nanoforming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nanoformed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Read more

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
NANOFH
FI4000330972
Nasdaq First North GM
Finland (FI)
Details of share in Nanoform Finland Oyj with ticker NANOFH
Status
Active
Order book id
Amount of instruments
66 600 443
Par value
Market cap
Currency
EUR
First trading date
04 Jun 2020
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
3.45 EUR
149.7M EUR
25 May - 02 Jun 2020
IPO in Nanoform Finland Oyj
Type
Ticker
ISIN
Market
SHARE
NANOFS
FI4000330972
Nasdaq First North GM
Sweden (SE)
Details of share in Nanoform Finland Oyj with ticker NANOFS
Status
Active
Order book id
Amount of instruments
66 600 443
Par value
Market cap
Currency
SEK
Segment
First North Premier
First trading date
04 Jun 2020
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
36.42 SEK
149.7M EUR
25 May - 02 Jun 2020
IPO in Nanoform Finland Oyj
People
Number of Employees
55 people
Edward Hæggström
CEO
Miguel Calado
Chairman of the board
Mads Laustsen
Board member
Albert Hæggström
Board member
Company Details
Sector
HEALTH CARE

Address
Viikinkaari 4
Zip code
FI-00790
City/district
Helsinki
Country
Finland (FI)
Registration number
2730572-8
LEI code
743700JJO2NU8LBS1592
First trade date
04 Jun 2020
Registration date
07 Dec 2015
Short name
Nanoform

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date